As it waits to close its landmark $66 billion purchase of Botox makerAllergan Inc. (AGN), Dublin pharmaceuticals company Actavis plc (ACT) has snapped up privately held U.K. generics maker Auden Mckenzie Holdings Ltd. for £306 million ($462 million).
Actavis said on Monday that the purchase will make it Britain's leading supplier of generic pharmaceuticals and will boost its non-GAAP earnings immediately. Actavis already markets more than 650 generics products in the U.K. and will ga...
Sign up today to gain access to 5 free articles a month from over 200 top subscription outlets.
Are you ready to take your business development to the next level with RelSci Professional?
Nurture your network with daily alerts that notify you when your relationships make news
Map your relationships to any target or prospect to identify a warm introduction
Access unlimited deep dossiers on over 8 million decision makers
Best of all, you can try out all these powerful business development tools absolutely free for 30 days!
Check out News Home to stay on top of the people and organizations you care most about.
